PCVX Earnings

Quarterly EPS
$-0.83
Q3 2024
$-1.01
Q4 2024
$-1.04
Q1 2025
$-1.22
Q2 2025
$-1.56
Q3 2025
$-1.81
Q4 2025
$-2.30
Q1 2026
$-1.97
Q2 2026
Latest RevenueN/A
Latest Net Income-284302000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.970-284302000-61.5%
Q1 2026-$2.300-320622000-121.2%
Q4 2025-$1.810-246507000-79.2%
Q3 2025-$1.560-212830000-88.0%
Q2 2025-$1.220-166573000-10.9%
Q1 2025-$1.040-140718000-22.4%
Q4 2024-$1.010-137080000+42.6%
Q3 2024-$0.830-103124000+8.8%
Q2 2024-$1.100-128703000
Q1 2024-$0.850-95020000
Q4 2023-$1.760-180801000
Q3 2023-$0.910-92664000
Vaxcyte (PCVX) — Earnings